Loading clinical trials...
Loading clinical trials...
Pilot Study of Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
Conditions
Interventions
Encorafenib
Binimetinib
+1 more
Locations
1
United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Start Date
June 14, 2018
Primary Completion Date
December 27, 2024
Completion Date
December 1, 2026
Last Updated
February 5, 2026
NCT05047094
NCT07349940
NCT05702398
NCT07287917
NCT06956690
NCT07410676
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions